Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Single HPV protein is required for cervical cancer growths to survive

Human papillomavirus (HPV) has long been implicated in cervical cancer, but details of how it happens have remained a mystery. Now researchers at the University of Wisconsin-Madison have found that a single HPV protein is required for cervical cancer and even pre-cancer growths in the cervix to survive.

17 Sep 2012

Research roundup: Reducing risk in shared savings programs

The Design And Application Of Shared Savings Programs: Lessons From Early Adopters --"Shared savings programs reward providers for holding spending below specific targets, thus introducing a level of financial accountability not present in strictly volume-based payment models, such as fee-for-service," researchers write.

7 Sep 2012

Uganda launches vaccination campaign against cervical cancer

"The government of Uganda has launched a vaccination campaign against cervical cancer -- the most common type of cancer among Ugandan women -- but there are already fears a nationwide rollout might be jeopardized by lack of funds," IRIN reports.

7 Sep 2012

Sanford Health researchers to explore origin of cervical cancer in American Indian women

A grant from the National Institutes of Health (NIH) is allowing Sanford Health researchers to explore the origin of cervical cancer in American Indian women.

1 Sep 2012

Quest Diagnostics announces availability of TERC test for cervical cancer

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer.

From Quest Diagnostics 31 Aug 2012

Declining circumcision rates in the US raise healthcare costs and disease risk

A team of disease experts and health economists at Johns Hopkins warns that steadily declining rates of U.S. infant male circumcision could add more than $4.4 billion in avoidable health care costs if rates over the next decade drop to levels now seen in Europe.

21 Aug 2012

Declining rates of circumcision in US infant males could add billions to health care costs

21 Aug 2012

HPV genotype may alter chemoradiotherapy outcome

Human papillomavirus genotype predicts whether patients with cervical cancer will benefit from concurrent chemoradiation therapy, study findings suggest.

20 Aug 2012

Birth control coverage mandate impacts doctors, women, religious groups

Physicians say they -- rather than insurers -- will feel the burden of the rule. Meanwhile, Republicans in Congress stay relatively quiet on the requirement, but tensions continue among Catholics and evangelical Protestants.

3 Aug 2012

Bloomberg Businessweek examines debate surrounding circumcision

Bloomberg Businessweek reports that "circumcision is in the spotlight again after a German court ruling has pitted those who support it for religious and health reasons against those who say boys should have the right to decide for themselves" and discusses how the procedure's role in "helping prevent the spread of AIDS in Africa" is "lost in the debate."

31 Jul 2012

HPV co-testing prospect for HIV-infected women

The risk for cervical precancer and cancer is similar in HIV-infected and HIV-uninfected women with normal cervical cytology and no evidence of oncogenic human papillomavirus infection, research shows.

30 Jul 2012

Treatment with robotic surgery offers dramatic benefit for people with head and neck cancer

Predictors of disease severity in human papillomavirus-derived head and neck cancer, tobacco use, and the dramatic benefits of robotic surgery in people with head and neck cancer are among landmark research presented by Mount Sinai School of Medicine at the Eighth International Conference on Head and Neck Cancer. The meeting took place from July 21-25, 2012 in Toronto.

27 Jul 2012

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

27 Jul 2012

Little evidence exists for potential HPV type competition in cross-sectional study

Vaccines against human papillomavirus (HPV) are now recommended by the Centers for Disease Control and Prevention for both teenage boys and girls. The vaccine protects against the two most common types of the virus that cause cervical cancer: HPV 16 and 18. Is there a chance that the increased number of people vaccinated might result in an increase of other types of HPV that cause cancer?

25 Jul 2012

HIV-positive women may use new methods to help reduce frequency of cervical cancer screening

Compared to the general population, HIV-positive women have a high risk of cervical cancer and thus are advised to undergo more frequent screening tests. This creates a burden for HIV-positive patients and the health care system, leading to frequent biopsies, which often do not reveal clinically relevant disease.

23 Jul 2012

Study: HIV-infected women less likely to develop cervical cancer

HIV-infected and uninfected women with normal cervical cytology (Pap test) and a negative test result for oncogenic (tumor inducing) human papillomavirus DNA at study enrollment had a similar risk of cervical precancer and cancer after 5 years of follow-up, according to a study in the July 25 issue of JAMA, a theme issue on HIV/AIDS.

23 Jul 2012

HPV positively impacts overall survival in African Americans with oropharyngeal cancer

Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry Ford Hospital researchers.

21 Jul 2012

High-risk HPV may increase chances of second malignancy in oral cancer

The proportion of oral squamous cell carcinoma patients infected with the human papillomavirus could be around a third, with high-risk versions of the virus accounting for almost three-quarters of those affected, indicate Taiwanese study results.

12 Jul 2012

Secure protocol allows linking of patient records without revealing personal information

Monitoring the effectiveness of the HPV vaccine in Canada requires that data from multiple registries and other data sources be combined. Linking registries can be problematic, however, since they are often managed by unrelated organizations. Privacy legislation may also restrict the sharing of data for such linkages.

12 Jul 2012

Maternal antiviral suppressive therapy may not be as effective as thought

Maternal antiviral suppressive therapy does not necessarily prevent the development of neonatal herpes simplex virus disease, warn researchers in The Journal of Pediatrics.

9 Jul 2012

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Single HPV protein is required for cervical cancer growths to survive

Research roundup: Reducing risk in shared savings programs

Uganda launches vaccination campaign against cervical cancer

Sanford Health researchers to explore origin of cervical cancer in American Indian women

Quest Diagnostics announces availability of TERC test for cervical cancer

Declining circumcision rates in the US raise healthcare costs and disease risk

Declining rates of circumcision in US infant males could add billions to health care costs

HPV genotype may alter chemoradiotherapy outcome

Birth control coverage mandate impacts doctors, women, religious groups

Bloomberg Businessweek examines debate surrounding circumcision

HPV co-testing prospect for HIV-infected women

Treatment with robotic surgery offers dramatic benefit for people with head and neck cancer

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

Little evidence exists for potential HPV type competition in cross-sectional study

HIV-positive women may use new methods to help reduce frequency of cervical cancer screening

Study: HIV-infected women less likely to develop cervical cancer

HPV positively impacts overall survival in African Americans with oropharyngeal cancer

High-risk HPV may increase chances of second malignancy in oral cancer

Secure protocol allows linking of patient records without revealing personal information

Maternal antiviral suppressive therapy may not be as effective as thought

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in